Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Pramipexole Monotherapy or Combination Therapy in Chinese Patients With Parkinson¿s Disease: a 12 Week Post Marketing Surveillance

NCT01361009 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01361009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01361009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Pramipexole Monotherapy or Combination Therapy in Chinese Patients With Parkinson¿s Disease: a 12 Week Post Marketing Surveillance
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
February 29, 2012
Enrollment
2,017 (actual)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease